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Abstract
Introduction: Polymyositis which is a rare disease both in general population and in pregnancy is
systemic connective tissue disorder characterized by inflammation and degeneration of muscles.
There is only a little information relating to the anesthetic management of a pregnant woman with
polymyositis.
Case presentation: In this article, we present anesthetic management of urgent cesarean delivery
of a 28-year-old parturient with polymyositis under epidural anesthesia who was diagnosed with
polymyositis five years ago and has been treated regularly with different doses prednisolone since
then.
Conclusion: In a parturient with polymyositis, it should not be suggested general anesthesia due
to risks including delayed recovery from muscle relaxation, aspiration pneumonitis, arrhythmias,
cardiac failure, we consider that epidural anesthesia for cesarean section can be safely applied.
Introduction
Polymyositis (PM) with the prevalence from 2.4-10.7
cases per 100.000 persons in the general population is
characterized by symmetric proximal muscle weakness,
increased serum skeletal muscle enzymes, electromyogra-
phy (EMG) abnormalities and inflammatory cell infil-
trates in muscle tissue. Hormonal factors, environmental
exposures and genetic factors are suggested to contribute
to the onset of this disease with unknown etiology [1,2].
While symmetrical, bilateral neck, shoulder, and pelvic
muscle weakness are seen in 50% of these patients; inter-
costal and diaphragmatic muscles and pharyngeal mus-
cles may also be affected. Although corticosteroids are the
mainstay of treatment, unresponsive patients or patients
who develop undesirable side effects are given immuno-
suppressant (azathioprine, cyclosporine, methotrexate) or
immunoglobulin [3,4]. We present our case report on the
grounds that there are only a few reports available in liter-
ature on the anesthetic management of polymyositis in
pregnant women [5,6]. Furthermore, in the case reports
on the operations of other patients who underwent
regional anesthesia, there was not enough information
about clinical course and muscle functions in postopera-
tive period.
Case Presentation
A 28-year-old, white, 158 cm tall, 68 kg primigravida
woman at 38 weeks' gestation was referred to our hospital
as her labor pain had started. She was diagnosed with pol-
ymyositis by muscle biopsy and EMG five years ago, and
the dose of prednisolone was readjusted due to muscle
weakness in pregnancy. For the last month of the preg-
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nancy, the dose of oral prednisolone has been inceased
from 5 mg to 30 mg once daily.
No family history of polymyositis or any muscular disor-
der was present. Preoperative physical examination was
normal. She had no history of respiratory and cardiac
problem. She was a non-smoker and no-drink alcohol.
Biochemistry results including liver enzymes (AST, aspar-
tate aminotransferase: 252 U/L, normal limits: ≤ 35 U/L;
ALT, alanine aminotransferase: 201 U/L, normal limits: ≤
40 U/L; LDH, lactate dehydrogenase: 1478 U/L, normal
limits: 240-480 U/L) and CK levels (creatine kinase: 1886
U/L, normal limits: ≤ 145 U/L) were high. Neurologic
examination on admission showed that muscle strength
was 4 (on a 0-5 Medical Research Council scale) for the
upper limb proximal muscles, 3 or 4 for the lower limb
proximal muscles, 4 for the hip flexion and 3 for the neck
flexion. She was found to have a cervical dilatation of 4
cm after the examination and thus the neurologist
together with the obstetrician decided on urgent cesarean
section owing to her muscles weakness which might lead
to difficulties in vaginal delivery.
After written informed consent approval, she was premed-
icated with metoclopramide (10 mg, i.v.) and ranitidine
(50 mg, i.v). Lactated Ringer's solution was started a rate
of 15 to 20 mL kg-1 per hour within 15-20 min before epi-
dural anesthesia. In the operating room, electrocardio-
graph, oxygen saturation via pulse oximetry (SpO2) and
noninvasive blood pressure were monitored (Datex-
Ohmeda AS/3 Helsinki, Finland). An epidural catheter
was inserted at the L4-5 interspace through an 18-gauge
Tuohy needle using loss of resistance to saline technique
in the lateral decubitus position and placed in 4 cm deep.
After epidural catheter placement, the patient was placed
supine on the operating table, with left uterine displace-
ment. Lateral uterine displacement until surgical incision
was achieved by tilting the operating table to 15°left. Sup-
plemental oxygen (4 L/min) by facemask was given until
delivery. A test dose of 2 mL of 2% lidocaine with
1:200000 epinephrine was given through the epidural
catheter. After verifying that there were no signs of intra-
vascular or intrathecal placement, epidural anesthesia was
induced with 16 mL of levobupivacaine 0.5% and 2 mL
fentanyl (100 μg), given in incremental doses of 5 mL
every two to three minutes. Sensory block height was eval-
uated by bilateral pinprick test at the midclavicular line
every two minutes. The operation started when sensorial
block level reached T4-5 at 11 minutes after anesthesia
induction. The time from surgical incision to delivery was
8 minutes, and the patient delivered a full-term healthy
baby (2520 g, 49 cm), with 5- and 10-minute Apgar scores
of 8 and 10, respectively. After delivery, we administered
10 U oxytocin in 500 mL crystalloid solution by slow
intravenous infusion. The patient was hemodynamically
stable and showed no signs of hypotension or bradycardia
throughout the operation. In the postpartum period, our
patient was monitored with a three-lead electrocardio-
gram (ECG), an automated, non-invasive, Datex Cardio-
cap blood pressure device, a pulse oximeter and a urinary
catheter. She was given morphine (two mg) through the
epidural catheter for postoperative analgesia and then the
catheter was removed after 12 hours. In the postoperative
period, the neurologist again evaluated the patient using
MRC (Medical Research Council scale) after the epidural
block regressed over a period of 115 minutes. Twenty-four
hours later, the patient's new EMG was compared with the
previous ones. Her muscle function showed no deteriora-
tion from the antepartum period. Our patient was safely
discharged home on the fifth postoperative day. Two
weeks later, the serum level of AST was 113 U/L, the serum
level of ALT was 108 U/L, the serum level of LDH was 940
U/L and the serum level of CK was 884 U/L. No improve-
ment in muscle functions was recorded in the patient's
controls after one and six months.
Discussion
Polymyositis is not common in pregnancy; however, the
possibility of development or exacerbation increases
when maternal hormonal changes occur. If the disease is
not in remission, it should be considered that both the
mother and the baby are under high-risk during preg-
nancy [7,8].
Points to be taken into consideration in the anesthetic
management are: respiratory insufficiency, aspiration
pneumonia, arrhythmias, cardiac failure and hyperkale-
mia [4]. It's believed that the patients with polymyositis
are sensitive to nondepolarising muscle relaxants, and the
use of their antagonist drugs may cause muscle weakness
and severe dysrrythmias [9]. Steroids induced myopathy
leads to an increased sensitivity to neuromuscular block-
ing drugs and an unpredictable response may be seen.
Doses usually have to be reduced upon titrating against
response. Furthermore, volatile anesthetic agents may not
only serve as a trigger of malignant hyperthermia but also
potentiate the effects of muscle relaxant. It is recom-
mended that these agents should be avoided in patients
with raised plasma creatine phosphokinase (CPK) levels.
Succinylcholine is also advised to be avoided as it may
serve as a trigger for malignant hyperthermia and lead to
hyperkalemia [4]. In addition, vecuronium and pancuro-
nium are associated with prolonged neuromuscular paral-
ysis [3,10]. Neuromuscular blockade monitorization
using a peripheral nerve stimulator is suggested due to
lack of standard recommendations regarding to the appli-
cation of nondepolarizing muscle relaxants [4,10,11].
There are some publications reporting that particularly
atracurium could be implemented as a safe drug under
neuromuscular monitoring [11,12]. However, someCases Journal 2009, 2:9107 http://www.casesjournal.com/content/2/1/9107
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researchers report that for endotracheal intubation or for
maintaining anesthesia, it would be appropriate to apply
regional techniques alone or combined with sedation, or
not to use muscle relaxant at all owing to limited sources
in the literature [13-15]. Fujita et al [15] performed tho-
racic epidural block, and no problems occurred during
and after the surgery so they showed epidural anesthesia
to be a successful method. Ohta et al [14] reported anes-
thetic management of two patients suffering from poly-
myositis, in one of which no muscle relaxation was used
for endotracheal intubation and maintenance of anesthe-
sia. The other patient was operated under epidural
anesthesia with sedation.
Safe, successful administration of regional anesthesia in
pregnant women requires an understanding of the normal
physiologic changes of pregnancy. At term, obstruction of
the inferior vena cava by the enlarging uterus distends the
epidural venous plexus and increases epidural blood vol-
ume. These effects cause a decrease in spinal cerebrospinal
fluid volume (CSF) and enhance the cephalad spread of
local anesthetic solutions during spinal and epidural
anesthesia. CSF volume inversely correlates with level of
anesthesia so decreasing CSF volume is associated with
higher blocks. In addition, Functional residual capacity
(FRC) begins to decrease by the fifth months of preg-
nancy. This is caused by elevation of the relaxed dia-
phragm, which occurs as the enlarging uterus enters the
abdominal cavity. Both vital capacity and closing capacity
are minimally affected but FRC decreases up to 20% at
term. The parturient is at greater risk than the nonpreg-
nant patient for developing airway closure and hypox-
emia during major regional anesthesia [16]. Regional
anesthesia can impair respiratory function by paralysis of
the intercostal muscles due to a high block although clin-
ically significant alterations in pulmonary physiology are
usually minimal with regional anesthesia. Satisfactory
regional anesthesia for cesarean delivery requires a block
level to at least the T5 dermatome and this can alter respi-
ratory performance [17]. Spinal anesthesia is an appropri-
ate choice for urgent cesarean sections. There is only one
case report on spinal anesthesia in pregnant women with
polymyositis in Medline [5]. One of the major disadvan-
tages of spinal anesthesia is higher incidence of hypoten-
sion. Although the rapid onset of spinal anesthesia is
often advantageous, the rapid onset of sympathetic block-
ade may result in abrupt, severe hypotension. Hypoten-
sion following spinal anesthesia in cesarean delivery is a
very common complication, with reported incidences var-
ying from 50% to 100% [18-20]. Thus, epidural anesthe-
sia may be a preference when physicians want to
minimize the likelihood of maternal hypotension or
when intense motor blockade of the thoracoabdominal
segments is not desired. Another advantage of epidural
anesthesia is postoperative pain relief [20]. We could pre-
fer spinal anesthesia in this parturient for urgent cesarean
section. However, we avoided high block levels which
effect respiratory muscles thus chose epidural anesthesia
as we could control block levels at ease. Furthermore we
wanted to minimize the likelihood of maternal hypoten-
sion and bradycardia and to achieve postoperative pain
relief. Besides, we needn't have hurried since there was no
sign of fetal distress.
Technique of combined spinal-epidural (CSE) might
especially benefit this patient. For cesarean section, it
combines the benefit of rapid, reliable, intense blockade
of spinal anesthesia together with the flexibility of an epi-
dural catheter. The catheter also allows supplementation
of anesthesia and can be used for postoperative analgesia.
In CSE applications, the spinal and epidural needles may
be placed at different interspaces, but most clinicians use
the same interspace as we did. However, when the same
interspace is used, epidurally administered drugs should
be administered and titrated carefully because the dural
hole created by the spinal needle increases the flux of epi-
dural drugs into cerebrospinal fluid and enhance their
effects [19]. In our case, owing to unpredictable high
blocks caused by these effects, we avoided CSE applica-
tion.
In the light of the information above, we refrained from
general anesthesia in our patient with high CPK level, who
was under treatment with corticosteroid for a long time,
due to the risk of aspiration and possible harmful results
of muscle relaxants and the use of antagonist drugs. Our
main concern during the anesthetic management of our
case was that there were only a few case reports in litera-
ture on anesthesia of pregnant women with polymyositis
[5,6].
Conclusion
As far as delayed recovery from muscle relaxation, aspira-
tion pneumonitis, arrhythmias, cardiac failure and steroid
supplementation with its complications are concerned as
the major concerns for an anesthesiologist; we consider
that epidural anesthesia for cesarean section in a pregnant
woman with polymyositis can be safely applied.
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